Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a global healthcare leader, has launched a share repurchase programme worth up to DKK 20 billion, which will unfold over 12 months starting from February 6, 2024. As part of this initiative, the company has begun repurchasing B shares with an allocation of DKK 2.2 billion for the period between May 7 and August 5, 2024. To date, Novo Nordisk has acquired 10,820,537 B shares at an average price of DKK 878.72 each, amounting to a total expenditure of DKK 9,508,271,105.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
